世界の経皮パッチ市場(~2026):投与量・価格・臨床試験インサイト

◆英語タイトル:Global Transdermal Patch Market, Dosage, Price and Clinical Trials Insight 2026
◆商品コード:KUIK21FB019
◆発行会社(リサーチ会社):Kuick Research
◆発行日:2020年1月
◆ページ数:384
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single userUSD2,800 ⇒換算¥319,200見積依頼/購入/質問フォーム
Multi UserUSD4,800 ⇒換算¥547,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はKuick Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Kuick Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本市場調査レポートでは、世界の経皮パッチ市場について調査・分析を行い、序論、経皮パッチの種類、経皮パッチのドラッグデリバリーメカニズム、市場動向、市場概要、経皮パッチの可用性・投与量・価格分析(心血管疾患用、神経学的障害用、ホルモン療法用、その他)、臨床パイプライン、市販用経皮パッチの臨床洞察、市場動向、今後の展望、競争状況などを掲載しています。
・序論
・経皮パッチの種類
・経皮パッチのドラッグデリバリーメカニズム
・市場動向
・市場概要
・経皮パッチの可用性・投与量・価格分析(心血管疾患用、神経学的障害用、ホルモン療法用、その他)
・臨床パイプライン
・市販用経皮パッチの臨床洞察
・市場動向
・今後の展望
・競争状況
【レポートの概要】

“Global Transdermal Patch Market, Dosage, Price and Clinical Trials Insight 2026″ Report Highlights:

Global Transdermal Patch Market Opportunity: > US$ 15 Billion
Global Transdermal Patch Clinical Pipeline: 100 Patches In Trials
Clinical Insight on 66 Commercially/Marketed Transdermal Patches
Global Transdermal Patch Clinical Trials Insight by Company, Drug Class, Indication and Patent Information
Regional Trends and Market Insight: US, Europe and Asia-Pacific
Dosage and Price Insight on Transdermal Patch
Global Transdermal Patch Market Future Prospects

The “Global Transdermal Patch Market, Dosage, Price and Clinical Trials Insight 2026″ research report unravels the in-depth analysis and present statistical and non-statistical information related to the current market trends that are prevalent at the global and regional level. In addition to this, the report successfully delivers the information about the sales , dosage and price of the medications that are delivered through this route. Report also discusses the ongoing clinical and non-clinical parameters with respect to development of global transdermal patch market and highlights the need for integration of transdermal patches in existing drug delivery methodology available to pharmaceutical companies.

Since the advent of the transdermal drug delivery technique, there has been a continuous rise in the market of transdermal patches globally. The market growth is attributed to the advantages that are associated with the patch technique such as painless and non-invasive administration of the medication, ease of administration and the prolonged activation of the drug inside the body. The availability of large number of transdermal delivery system in the market is continuously proving to be a breakthrough and is currently undergoing by huge commercial success.

Transdermal patches offer many benefits over traditional drug delivery methodologies like pill, powder, or liquid medication. The most important and the fundamental benefit of using patches is the direct-to-bloodstream delivery while bypassing the liver’s metabolic activity. This method of drug delivery is therefore a boon to the patients suffering from hepatic disorders as stress to the liver is simply bypassed. A patient’s body heat activates a patch, prompting it to begin releasing medication through the skin and into the bloodstream. Thus, the innovators have enough good need for development of medications mediating through this drug delivery system.

Transdermal patches can be designed to provide prolonged and controlled release of certain drugs, which can be convenient for pain-relief drugs, nicotine, and hormone products. For instance, granisetron transdermal system is a transdermal patch used to treat chemotherapy-induced nausea and vomiting in a regulated way. The alternative forms – intravenous injections and oral tabletsandmdash;both pose challenges for patients, whereas transdermal delivery provides a more comfortable and patient-friendly delivery method.

It can be well witnessed that the patch technology is playing its part and the medication in this segment have improved a lot. Clinicians wherever possible and required are more of inclined towards its use; reasons maybe several either the condition of the patient or the extra-long duration of the therapy. The need of transdermal patch drug delivery has already gained momentum and is sure to play its part in the global pharmaceutical market.

【レポートの目次】

Prologue to Transdermal Patch
1.1 Overview of Transdermal Patch
1.2 Relevance of Transdermal Patch

Types of Transdermal Patches
2.1 Single/ Multiple-Layer Drug-in-Adhesive
2.2 Reservoir Transdermal Patches
2.3 Matrix Based Transdermal Patches
2.4 Vapor Patch
2.5 Active and Passive Patch

Mechanism of Transdermal Patch Drug Delivery
3.1 Properties of Transdermal Therapeutics
3.2 Components of Transdermal Patch
3.3 Mechanism of Motion Sickness, Nicotine and Female Contraceptive Transdermal Patch
3.4 Transdermal Patch v/s Traditional Drug Delivery Methods

Global Transdermal Patch Market Insight
4.1 Global Market Scenario
4.2 Regional Market Trends
4.2.1 United States
4.2.2 Europe
4.2.3 Asia Pacific

Transdermal Patches for Cardiovascular Diseases – Availability, Dosage and Price Analysis
5.1 Clonidine Transdermal Patch (Catapres–TTS)
5.2 Nitro Glycerin Transdermal Patch
Opioid Drug Containing Transdermal Patches – Availability, Dosage and Price Analysis
6.1 Fentanyl Transdermal Patch (Duragesic)
6.2 Buprenorphine Transdermal Patch (Butrans Patch)

Transdermal Patches for Neurological Disorders – Availability, Dosage and Price Analysis
7.1 Selegiline Transdermal Patch (Emsam)
7.2 Scopolamine Transdermal Patch (Transderm-Scop)
7.3 Rivastigmine Transdermal Patch (Exelon)
7.4 Methylphenidate Transdermal Patch (Daytrana)

Transdermal Patch in Hormonal Therapy – Availability, Dosage and Price Analysis
8.1 Estradiol Transdermal Patch
8.1.1 Alora
8.1.2 Vivelle-Dot
8.2 Testosterone Transdermal Patch (Androderm)
8.3 Ethinyl Estradiol and Norelgestromin Transdermal Patch (Xulane)

Transdermal Patches for Other Conditions – Availability, Dosage and Price Analysis
9.1 Nicotine Transdermal Patch (Nicoderm CQ)
9.2 Oxybutynin Transdermal Patch (Oxytrol)

Global Transdermal Patch Clinical Pipeline Overview
10.1 By Phase
10.2 By Region/Country
10.3 By Drug Class/Molecule
10.4 By Company
10.5 By Orphan and Fast Track Status
10.6 By Mode of Action

Global Patch Clinical Pipeline By Company, Indication and Phase
11.1 Unknown
11.2 Research
11.3 Preclinical
11.4 Clinical
11.5 Phase-I
11.6 Phase-I/II
11.7 Phase-II
11.8 Phase-III
11.9 Preregistration
11.10 Registered

Marketed Transdermal Patch Clinical Insight

Global Transdermal Patch Market Dynamics
13.1 Favorable Market Parameters
13.2 Commercialization Challenges

Global Transdermal Patch Market Future Outlook 2026

Competitive Landscape
15.1 3M Pharmaceuticals
15.2 Acrux
15.3 Agile Therapeutics
15.4 Allergan
15.5 ANI Pharmaceuticals
15.6 Antares Pharma
15.7 Bayer HealthCare Pharmaceuticals
15.8 Corium International
15.9 Chase Pharmaceuticals
15.10 DURECT Corporation
15.11 Endo Pharmaceuticals
15.12 Fempharm
15.13 Hisamitsu Pharmaceutical
15.14 Immune Pharmaceuticals
15.15 Imprimis Pharmaceuticals
15.16 Ipsen Bioscience
15.17 Johnson and Johnson
15.18 LaSalle Laboratories
15.19 Lavipharm-increase
15.20 MINRAD International
15.21 NeurogesX
15.22 Noven Pharmaceuticals
15.23 NuPathe
15.24 Nuvo Research
15.25 Novartis
15.26 Pain Therapeutics
15.27 ProStrakan
15.28 Purdue Pharma
15.29 Sanofi
15.30 Scilex Pharmaceuticals
15.31 Senju Pharmaceutical
15.32 Somerset Pharmaceuticals
15.33 Teikoku Seiyaku
15.34 Therapeutic Discovery Corporation
15.35 Transdermal Delivery Solutions Corp
15.36 UCB
15.37 Xel Pharmaceuticals
15.38 Zosano Pharma



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の経皮パッチ市場(~2026):投与量・価格・臨床試験インサイト]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆